Rhythm Biosciences Limited (FRA:0RY)
Germany flag Germany · Delayed Price · Currency is EUR
0.1170
-0.0050 (-4.10%)
Last updated: Feb 20, 2026, 3:25 PM CET

Rhythm Biosciences Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Other Revenue
3.193.191.693.12.431.11
Revenue
1.653.191.693.12.431.11
Revenue Growth (YoY)
-47.96%88.85%-45.41%27.54%118.98%1008.51%
Cost of Revenue
0.630.223.05---
Gross Profit
1.012.97-1.363.12.431.11
Selling, General & Admin
6.035.1237.75.993.03
Research & Development
1.381.382.353.655.164.55
Amortization of Goodwill & Intangibles
---0.040.040.04
Operating Expenses
7.626.75.5511.5411.257.73
Operating Income
-6.6-3.73-6.91-8.44-8.82-6.62
Interest Expense
-0.08-0.07-0-0.01--0
Interest & Investment Income
0.070.130.050.230.020.01
EBT Excluding Unusual Items
-6.61-3.66-6.86-8.22-8.79-6.61
Merger & Restructuring Charges
-0.07-0.17----
Pretax Income
-6.68-3.83-6.86-8.22-8.79-6.61
Net Income
-6.68-3.83-6.86-8.22-8.79-6.61
Net Income to Common
-6.68-3.83-6.86-8.22-8.79-6.61
Shares Outstanding (Basic)
300269228217210185
Shares Outstanding (Diluted)
300269228217210185
Shares Change (YoY)
22.10%17.94%5.26%3.31%13.35%83.84%
EPS (Basic)
-0.02-0.01-0.03-0.04-0.04-0.04
EPS (Diluted)
-0.02-0.01-0.03-0.04-0.04-0.04
Free Cash Flow
-6.14-2.94-6.22-7.06-6.52-5.47
Free Cash Flow Per Share
-0.02-0.01-0.03-0.03-0.03-0.03
Gross Margin
61.47%92.95%-80.31%100.00%100.00%100.00%
Operating Margin
-400.74%-116.85%-408.60%-272.60%-363.29%-597.64%
Profit Margin
-405.14%-119.97%-405.69%-265.44%-362.26%-596.49%
Free Cash Flow Margin
-372.52%-92.25%-367.98%-227.94%-268.74%-493.52%
EBITDA
-6.4-3.53-6.71-8.34-8.72-6.52
EBITDA Margin
--110.68%--269.35%--
D&A For EBITDA
0.20.20.20.10.090.11
EBIT
-6.6-3.73-6.91-8.44-8.82-6.62
EBIT Margin
--116.85%--272.60%--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.